logo
ResearchBunny Logo
CD5L as a promising biological therapeutic for treating sepsis

Medicine and Health

CD5L as a promising biological therapeutic for treating sepsis

L. Oliveira, M. C. Silva, et al.

Discover the groundbreaking research by Liliana Oliveira and colleagues that unveils the therapeutic potential of CD5L in treating experimental sepsis. This study reveals how CD5L boosts neutrophil responses, enhances phagocytosis, and improves survival rates in mice, pointing towards a promising avenue for human treatments.

00:00
00:00
Playback language: English
Abstract
This study demonstrates the therapeutic potential of CD5L in treating experimental sepsis. CD5L enhances neutrophil recruitment and activation, promotes phagocytosis, and lowers endotoxin and DAMP levels. CD5L-deficient mice exhibit impaired immune responses and decreased survival. Recombinant CD5L significantly improves sepsis outcomes in mice, warranting further investigation as a potential human treatment.
Publisher
Nature Communications
Published On
May 15, 2024
Authors
Liliana Oliveira, M. Carolina Silva, Ana P. Gomes, Rita F. Santos, Marcos S. Cardoso, Ana Nóvoa, Hervé Luche, Bruno Cavadas, Irina Amorim, Fátima Gärtner, Bernard Malissen, Moisés Mallo, Alexandre M. Carmo
Tags
CD5L
sepsis
neutrophils
immune response
recombinant CD5L
phagocytosis
endotoxin
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny